FIELD: medicine; pharmaceutics.
SUBSTANCE: invention relates to ophthalmology and can be used for treating myopia. Disclosed is use of a compound of formula (I) or a pharmaceutically acceptable salt thereof in preparing a drug for treating myopia and/or amblyopia.
EFFECT: use of said compound provides effective treatment with fewer side effects compared to atropine.
4 cl, 2 dwg, 6 tbl, 4 ex
Authors
Dates
2024-11-25—Published
2021-09-28—Filed